Evidence map›Paper›PMID 32728982›Full record

ReviewHerzschrittmachertherapie & Elektrophysiologie2020

[Innovations in invasive electrophysiology : What awaits us?]

Patrick Müller, Lars Eckardt

Abstract readReview
PubMed Publisher
In one paragraph

Review in Herzschrittmachertherapie & Elektrophysiologie, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. [Starting cardiac electrophysiology-practical guidance].Herzschrittmachertherapie & Elektrophysiologie · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Patrick MüllerKlinik für Kardiologie II, Rhythmologie, Universitätsklinikum Münster, 48149, Münster, Deutschland. Patrick.Mueller@ukmuenster.de.
Lars EckardtKlinik für Kardiologie II, Rhythmologie, Universitätsklinikum Münster, 48149, Münster, Deutschland. Lars.Eckardt@ukmuenster.de.
Klinik und Poliklinik für Psychosomatik und Psychotherapie · DEUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Technological developments in percutaneous catheter ablation for the treatment of cardiac arrhythmias have progressed from direct current shock ablation over the introduction of radiofrequency ablation to routine clinical procedures. Invasive electrophysiology is characterized by continuous technical innovation and an accompanying increasing understanding of underlying electrophysiologic mechanisms. A number of technical developments were promising, e.g., laser ablation, multipolar biphasic ablation, cryoballoon ablation, contact force, high density three-dimensional (3D) mapping, and the concept of rotors for atrial fibrillation ablation. Despite intense progress, one of the main challenges of catheter ablation is still the creation of tissue-specific chronic transmural lesions and avoidance of collateral damage. The purpose of this review is to present a status quo of catheter ablation of supraventricular tachycardia, atrial fibrillation, and ventricular tachycardia and to discuss future technical innovations and strategies. In the presence of the intense dynamic developments, this review can not consider all new approaches but will rather highlight some of the most promising innovations. Topics of discussion include the use of nonfluoroscopic catheter navigation, the introduction of new ablation tools, the development of alternative energy sources, the integration of new imaging modalities, and the establishment of novel ablation strategies.

Indexed as

Atrial FibrillationCatheter AblationTachycardia, SupraventricularTachycardia, VentricularCardiac ElectrophysiologyHumansArrhythmiaCatheter ablationIsochronal late activation mappingPulsed field ablationThree-dimensional mapping

Identifiers

PMID32728982
OpenAlexW3045783793

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.